Announcements

Christopher Counter, PhD, associate director of Basic Research, is a member of a group receiving an international Cancer Grand Challenges Grant to investigate origins of cancer.

DCI cancer disparities and healthcare delivery researchers Steven Patierno, PhD, and Nadine Barrett, PhD, are part of national efforts to mitigate cancer health disparities.

Whether you’re a cancer survivor, friend, loved one, or medical professional, this is a day for everyone.

DCI member Christopher Willett, MD, has been named the Mark W. Dewhirst Distinguished Professor of Radiation Oncology.

Duke Cancer Institute member Paul Modrich, PhD, chose Duke in 1976 and the next 46 years was history.

DCI member Raphael Valdivia, PhD, has been named the Nanaline Duke Distinguished Professor of Molecular Genetics and Microbiology.

DCI member and physician-scientist Sandeep Dave, MD, MS, has been named the Wellcome Clinical Distinguished Professor of Medicine.

DCI pathologist Jeffrey Marks, PhD, has been named "Joseph W. and Dorothy W. Beard Distinguished Professor of Experimental Surgery."

DCI surgical oncologist and researcher Sabino Zani, Jr, MD, specializes in cancers of the liver and pancreas.

Three DCI faculty and physician leaders are utilizing their talents in new roles to ensure DCI patients continue to have the safest and best-quality care possible.

The Duke Cancer Institute is excited to announce the establishment of the Duke Sarcoma Center, a center of excellence for sarcoma treatment and research.

An endowed professorship for David Harpole, Jr., MD, will support his ongoing translational and clinical research in lung cancer.

The risk of dying from cancer continues to drop at an accelerated pace. Some of this drop appears to be related to lung cancer patients living longer after diagnosis.

The U.S. Senate confirmation of Robert Califf, MD, as FDA Commissioner was hailed by his colleagues in the world of clinical research and academic medicine.

Susan Dent, MD, FRCPC, associate director, Clinical Research, DCI Breast Cancer Disease Group, has joined the Duke IBC Consortium as clinical director.

New NCCN cervical cancer patient guidelines were released in December. Junzo Chino, MD, is on the guidelines panel.

Duke Cancer Institute's Arif Kamal, MD, MBA, MHS, FACP, FAAHPM, FASCO, will lead patient support to improve lives of cancer patients.

Special "Drivers for a Cure" license plates are now being offered in South Carolina. Proceeds benefit DCI and  MUSC Hollings Cancer Center research.

The $50,000 grant will support research by Chuan-Yuan Li, DSc, into the ability of cholesterol-lowering drugs to boost cancer-drug immunotherapies.

Jacob Keller, MHA, has joined DCI as administrative director for Hematologic Malignancies & Cellular Therapies, effective January 1.

Gerald Grant, MD, returns to Duke from Stanford University, where he's an endowed professor and chief of Pediatric Neurosurgery.

Cancer can change how you look and feel about yourself as you go through treatment and into survivorship. DCI's self-image program can help.

POSTPONED Annual Benefit Gala to celebrate 30 years of Caring House. Donald & Mary McDonnell to be honored for more than a decade of support.

Furong Huang PhD, a postdoctoral fellow in the Wang Lab, received a Department of Defense Prostate Cancer Research Program Early Investigator Award.

Looking for a great read on how to develop, integrate, & implement a comprehensive cancer center? A new open-access book co-authored by Nelson Chao, MD, MBA, is now available.

Holly Dressman has been named director of Duke’s Sequencing and Genomic Technologies (SGT) Core Facility. Nicolas Devos, PhD, has stepped down from his role as SGT director.

Community outreach & engagement teams from DCI, Wake Forest and UNC cancer centers have launched an initiative focused on the cancer-related health needs of American Indian communities.

Former Blue Devil Maggie DiNome, MD, a breast surgical oncologist, joined Duke from UCLA as medical director of Wake County Breast Cancer Services and as a professor of Surgery.

Haley Moss, MD, MBA, will work to expand access to care for women veterans through teleoncology and clinical trials in new role at the U.S. Dept. of Veterans Affairs.

In his new NIH role, Ginsburg will help direct the national scientific research agenda to improve health and accelerate research using precision medicine.

Executive director of talent management for Duke Health Development and Alumni Affairs Jeff Chitester, MS, MA, named DCI CHRO, effective 11.3.21.

Sydnee Crankshaw, MPA, has been named Senior Research Program Leader for DCI’s "Cancer Prevention and Control" and "Cancer Risk, Detection, and Interception" programs.

Among her many roles, LeAnn Hinson, RN, MSN, served DUHS and DCI as a CHRO and worked as a gynecologic oncology nurse and Life Flight nurse.

Beloved co-worker, mother, wife, daughter, friend, and patient-champion, Erin Duffy Wood, has passed away after a 15-year battle with colon cancer.

The 8^th Annual DCI Scientific Retreat will be held via Zoom on Friday, Dec. 3, 2021 from 12:30 p.m. to 5 p.m. Keynote: UCSF's Alan Ashworth, PhD, FRS.

The metastatic breast cancer research grants, made possible by Susan G. Komen, bring together patient advocates and DCI & UNC Lineberger investigators.

The $3 million National Science Foundation grant is for training Master’s and PhD students at Duke in engineering, computer science, data science, & surgical technologies.

Duke Cancer Institute member Joseph Heitman, MD, PhD, has been elected to the German National Academy of Sciences Leopoldina.

Dukes receives two large grants totaling nearly $12 million from the National Human Genome Research Institute (NHGRI) as part of its new Impact of Genomic Variation on Function (IGVF) Consortium.

The new Duke Blood Cancer Center opens up the opportunity to transition some cancer treatments from the inpatient to the outpatient setting and the infusion room is open every day.

DCI's Melanoma (and advanced skin cancer) Disease Group expands Clinic 5-1 services to include dermatological cancer care for patients who require multidisciplinary care.

Shelley Hwang, MD, vice chair of Research in the Department of Surgery, is renowned for her work in pre-invasive breast cancer.

The FASTRO designation honor recognizes exceptional service to the field of radiation oncology and cancer care.

DCI molecular biologist Jason Somarelli, PhD, utilizes comparative and evolutionary biology in his cancer research.

J. Michael Cook, PhD, assistant professor in the Department of Immunology and co-leader of the Flow Cytometry Shared Resource has passed away.

Oncology faculty and providers among 2021 Duke Clinical Leadership Program 2021 graduates, including the winning project team.

Christopher Counter, PhD, Devon Noonan, PhD, MPH, Charles Gersbach, PhD, Fang-Fang Yin, PhD, Sue Jinks-Robertson, Deborah Muoio, PhD, awarded distinguished professorships.

One of the Neil L. Spector Art of Medicine awardees is DCI member Kimberly Johnson, MD, MHS.

The 4th floor of the new South Pavilion at Duke Raleigh Hospital will be utilized primarily for surgical oncology inpatients.

DCI scientist Ehsan Samei, PhD, Professor of Radiology, Physics, Biomedical Engineering, and Electrical and Computer Engineering, is director of the Center for Virtual Imaging Trials.